What are the mechanisms of action for each class of antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanisms of Action for Antibiotic Classes

β-Lactam Antibiotics (Penicillins, Cephalosporins, Carbapenems)

β-lactam antibiotics inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), specifically blocking the transpeptidase and DD-carboxypeptidase enzymes that cross-link peptidoglycan chains in the final stages of murein biosynthesis. 1

  • The β-lactam ring structure has steric similarity to the D-alanyl-D-alanine dipeptide substrate, causing the enzyme to act on the antibiotic instead of the natural substrate 2
  • This results in incomplete cell wall formation, producing fragile bacteria that cannot maintain structural integrity 2
  • β-lactams are bactericidal agents that kill in a time-dependent fashion, with efficacy dependent on the time that serum concentration remains above the organism's minimal inhibitory concentration (MIC) 1
  • Most β-lactams achieve less than 50% of their serum concentration in lung tissue, which affects dosing strategies 1
  • β-lactams generally have minimal or short post-antibiotic effect (PAE) against gram-negative bacilli, except for carbapenems (imipenem, meropenem) which demonstrate PAE against organisms like P. aeruginosa 1
  • Optimal dosing requires frequent administration or continuous infusion to maintain levels above the MIC for as long as possible 1

Fluoroquinolones (Ciprofloxacin, Levofloxacin)

Fluoroquinolones are bactericidal agents that inhibit bacterial DNA replication by blocking topoisomerase II (DNA gyrase) and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination. 3

  • These agents kill bacteria in a concentration-dependent fashion, killing more rapidly at higher concentrations 1
  • Fluoroquinolones exhibit a prolonged post-antibiotic effect (PAE) against gram-negative bacilli, allowing for less frequent dosing 1
  • They achieve lung concentrations equal to or exceeding serum concentrations in bronchial secretions, providing excellent tissue penetration 1
  • The mechanism of action differs completely from penicillins, cephalosporins, aminoglycosides, macrolides, and tetracyclines, meaning organisms resistant to these classes may remain susceptible to quinolones 3
  • Optimal dosing involves maximizing initial serum concentrations, with once-daily dosing taking advantage of both concentration-dependent killing and the post-antibiotic effect 1

Aminoglycosides (Gentamicin, Tobramycin, Amikacin)

Aminoglycosides bind irreversibly to the 30S ribosomal subunit, causing misreading of mRNA and producing defective proteins, ultimately leading to bacterial cell death. 1

  • Specifically, the 3'-OH function reacts with lysine from the S12 protein component of the 30S subunit 2
  • This causes alteration in mRNA reading, false translation, cessation of protein biosynthesis, decrease in polyribosomes, and formation of inert 70S ribosomes 2
  • Aminoglycosides are bactericidal in a concentration-dependent fashion, killing more rapidly at high concentrations 1
  • They demonstrate a prolonged post-antibiotic effect (PAE) against gram-negative bacilli 1
  • Once-daily dosing maximizes efficacy by combining concentration-dependent killing with the post-antibiotic effect, though clinical trials show conflicting results regarding toxicity reduction 1

Macrolides and Azalides (Erythromycin, Clarithromycin, Azithromycin)

Macrolides inhibit bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, blocking the transpeptidation/translocation step and preventing assembly of the 50S ribosomal subunit. 1, 4, 5

  • Azithromycin specifically binds to the 23S rRNA at positions corresponding to A2058 and A2059 in the E. coli numbering system 5
  • These agents are generally bacteriostatic, though they can be bactericidal against autolytic species like pneumococci 1
  • Macrolides concentrate in phagocytes and fibroblasts, with intracellular to extracellular concentration ratios exceeding 30:1 after one hour 5
  • Azithromycin penetrates gram-negative bacterial cells more effectively than erythromycin due to better permeability across the outer cell envelope 1
  • Activity is pH-dependent, with better antibacterial activity in neutral to basic environments; at low pH, macrolides become positively charged and cannot readily cross biological membranes 1

Glycopeptides (Vancomycin)

Vancomycin is bactericidal in a time-dependent fashion, with killing dependent on the time that serum concentration remains above the organism's MIC. 1

  • The degree of bacterial killing depends on maintaining adequate drug levels above the MIC rather than achieving high peak concentrations 1
  • This time-dependent mechanism requires dosing strategies that maintain therapeutic levels throughout the dosing interval 1

Oxazolidinones (Linezolid)

Linezolid inhibits bacterial protein synthesis through a unique mechanism, and is bacteriostatic in vitro against enterococci. 6

  • Linezolid achieves lung concentrations equal to or exceeding serum concentrations in bronchial secretions 1
  • The American Heart Association notes the bacteriostatic nature as a potential limitation in serious infections like endocarditis 6
  • In immunocompromised patients or deep-seated infections, combination therapy or alternative agents may be considered due to its bacteriostatic activity 6

Ketolides (Telithromycin)

Ketolides have a mechanism similar to macrolides but with higher affinity for the 23S rRNA target binding sites on the 50S ribosomal subunit, providing greater activity against macrolide-resistant strains. 1

  • Ketolides exhibit concentration-dependent antimicrobial killing 1
  • Structural modifications prevent ribosomal methylase-mediated resistance common with macrolides, and may retain activity against strains with erm determinants 1
  • AUC/MIC ratios of approximately 200 correlate with bacteriostatic activity, while ratios ≥1000 are needed for bactericidal activity 1

Tetracyclines (Doxycycline)

Tetracyclines inhibit bacterial protein synthesis by reversibly binding to the 30S ribosomal subunit, preventing binding of transfer RNA (t-RNA). 1

  • This mechanism blocks RNA-dependent protein synthesis 1
  • Tetracyclines are generally bacteriostatic agents 1

Rifamycins (Rifampin)

Rifampin binds to the β subunit of bacterial RNA polymerase, blocking RNA transcription by suppressing the initiation of chain formation, resulting in bactericidal activity. 1, 2

  • Hydroxyl and ketone functions at specific positions link to the β subunit of RNA polymerase, causing conformational changes in the RNA polymerase-DNA complex 2
  • This inhibits the catalytic action of the enzyme, stopping RNA messenger and protein synthesis 2
  • Rifampin is active against intracellular and extracellular microorganisms, including gram-positive and gram-negative bacteria 1
  • Resistance develops rapidly with monotherapy, so it should not be used alone or for prolonged duration 1

Lincosamides (Clindamycin)

Clindamycin binds to the 50S ribosomal subunit of susceptible bacteria, suppressing protein synthesis through a concentration-dependent mechanism. 1

  • Despite structural differences from macrolides, clindamycin acts at overlapping ribosomal binding sites 1
  • It demonstrates concentration-dependent antimicrobial activity 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Mechanism of action of antibiotics:some examples].

Comptes rendus des seances de la Societe de biologie et de ses filiales, 1978

Guideline

Antibiotic Mechanisms and Resistance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Linezolid Mechanism and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.